Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CDK 4/6
Pharma
Pfizer's Ibrance scores in double-positive breast cancer
Looking beyond HR+/HER2- breast cancer, Pfizer has found a unique opportunity for Ibrance in HR+/HER2+ tumors.
Angus Liu
Dec 12, 2024 8:15am
ASCO: Lilly seeks prostate cancer redemption after Verzenio flop
May 23, 2024 5:00pm
SABCS: Novartis gives update on Kisqali in early breast cancer
Dec 8, 2023 9:15am
Lilly's Verzenio barely misses overall survival goal in 1L
Dec 6, 2023 10:00am
ASCO: Novartis details Kisqali's adjuvant breast cancer win
Jun 2, 2023 8:00am
Pfizer unveils mysterious Ibrance breast cancer nod
Jan 31, 2023 2:52pm
